Scientists develop RNA-based technology to combat plant viruses, enhancing crop immunity and reducing losses worldwide.

Although Paxlovid did not demonstrate widespread efficacy, a novel approach to long COVID research has emerged.

Researchers have developed new drug candidates that show great promise against the virus that causes COVID-19 and potentially ...

A team at UC San Francisco and Gladstone Institutes has developed new drug candidates that show great promise against the virus that causes COVID-19 and potentially other coronaviruses that could ...

A study by former Junior Associate Professor Kazuo Takayama, currently a professor of the Institute of Science Tokyo, ...

HealthDay News — A single-dose baloxavir treatment can reduce influenza transmission from index patients to household contacts, according to a study published in the April 24 issue of the New England ...

A single dose of the antiviral baloxavir marboxil (Xofluza) led to a lower incidence of influenza virus transmission to ...

Fewer cases of chronic hepatitis C virus are reported each year in Alaska, but rates remain higher among men, younger adults, ...